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Abstract: Objective: To compare the rates of fetal growth restriction (FGR) in singleton and
twin pregnancies using singleton and twin-specific birthweight standards. Methods: The study
included liveborn twin and singleton pregnancies between January 2000 and January 2019.
Hypertensive disorders of pregnancy (HDP) included gestational hypertension and pre-eclampsia.
The study outcomes were FGR or small-for-gestational-age (SGA) at birth as assessed using
singleton and twin reference charts. Results: The analysis included 1473 twin and 62,432 singleton
pregnancies. In singleton pregnancies the risk of PTB <34 weeks without HDP (OR 2.82, p < 0.001),
delivery ≥34 weeks with HDP (OR 2.38, p < 0.001), and PTB <34 weeks with HDP (OR 13.65,
p < 0.001) were significantly higher in the pregnancies complicated by FGR compared to those
without. When selective fetal growth restriction (sFGR) was assessed using the singleton standard,
the risk of PTB <34 weeks without HDP (OR 1.03, p = 0.872), delivery ≥34 weeks with HDP (OR 1.36,
p = 0.160) were similar in the pregnancies complicated by sFGR compared to those without, while the
risk of PTB <34 weeks with HDP (OR 2.41, p = 0.025) was significantly higher in the pregnancies
complicated by sFGR compared to those without. When sFGR was assessed using the twin-specific
chart, the risk of PTB <34 weeks without HDP (OR 3.55, p < 0.001), delivery ≥34 weeks with HDP
(OR 3.17, p = 0.004), and PTB <34 weeks with HDP (OR 5.69, p < 0.001) were significantly higher in
the pregnancies complicated by sFGR compared to those without. The stronger and more consistent
association persisted in the subgroup analyses according to chorionicity. The strength of association
in dichorionic twin pregnancies resembles that of the singletons more closely and consistently when
the FGR was diagnosed using the twin-specific charts. Conclusion: FGR in twin pregnancies has a
stronger and more consistent association with HDP and PTB when using twin-specific rather than
singleton charts. This study provides further evidence supporting the use of twin-specific charts
when assessing fetal growth in twin pregnancies.
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1. Introduction
Twin pregnancies constitute 1.6% of all births but they contribute disproportionately to the perinatal
mortality and morbidity by representing 20% of preterm births and 5.9% of stillbirths [1]. Empirical
evidence suggests that the implementation of national guidelines, based on twin-specific research,
could reduce stillbirth and neonatal death in twin pregnancies [2,3]. Nevertheless, stillbirth and
neonatal death are still more common in twin compared to singleton pregnancies [4]. Therefore, more
research efforts are needed first to understand the reasons, second to identify potential interventions to
reduce the risk of perinatal mortality and morbidity, and third to identify the challenges to implement
these interventions.
Preterm birth (PTB), growth disorders and monochorionicity-related complications are among
the most important contributors to the excess perinatal mortality and morbidity in twin pregnancies.
Furthermore, growth assessment in twins has been identified by the Global Twins and Multiples
Priority Setting Partnership as one of the 10 most important research priorities for the future health of
multiples and their families [5]. Twin-specific growth and birthweight charts are available but their
use in clinical practice is currently controversial [6–8]. Most studies use singleton standards for the
evaluation of twins [9,10], but the results of these studies may change significantly if twin-specific
standards are used [11]. Moreover, the diagnostic criteria for selective fetal growth restriction (sFGR)
do not recommend a specific reference standard to use, despite including weight percentile thresholds
as part of the diagnostic criteria [12,13]. An evidence-based consensus on the management of growth
restriction in twins is unlikely to be achievable before the harmonization of which reference standards
to use while assessing the fetal growth or birthweight [14–17].
Recent evidence has demonstrated that the use of twin-specific charts better identifies the
pregnancies at increased risk of adverse perinatal outcome [18,19]. However, there is a general
reluctance to take up their use into routine clinical practice, as the use of twin charts is still considered
controversial. This study aims to compare the association of FGR with hypertensive disorders in
pregnancy (HDP) and PTB in singleton and twin pregnancies using singleton versus twin-specific
birthweight standards.
2. Experimental Section
2.1. Study Population
This was a cohort study with retrospective analysis of prospectively collected data of unselected
liveborn twin and singleton pregnancies at St George’s Hospital between January 2000 and January
2019. Pregnancies were identified by searching the electronic maternity records (ViewPoint version
5.6.26.148, ViewPoint Bildverarbeitung GMBH, Wessling, Germany). The exclusion criteria included
major fetal structural anomalies or aneuploidy; twin-to-twin transfusion syndrome (TTTS); twin
reversed arterial perfusion sequence (TRAPS); twin anemia–polycythemia sequence (TAPS); missing
gestational age at delivery, birthweight or HDP data; and women with pre-pregnancy hypertension.
Pregnancy outcomes were ascertained from the maternity database and neonatal records.
2.2. Study Variables and Outcomes
The chorionicity was determined based on the number of placentas and the presence or absence
of the lambda sign at the intertwin membrane–placenta junction, as well as the inter-twin membrane
thickness at the site of its insertion in the chorion at 11–14 weeks, or the number of placentas and
the fetal gender after 14 weeks’ gestation [19,20]. Gestational age (GA) was determined in the first
trimester according to the crown-rump length of the fetus (singleton pregnancies) or the larger fetus
(twin pregnancies) in cases of spontaneous conception and according to the time of in vitro fertilization
for pregnancies conceived via assisted reproductive technology [21]. After 14 weeks’ gestation, GA
was determined using the head circumference of the fetus (singleton pregnancies) or the larger fetus
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(twin pregnancies) in cases of spontaneous conception and according to the time of in vitro fertilization
for pregnancies conceived via assisted reproductive technology [19,22].
Small-for-gestational-age (SGA) was defined as birthweight centile below the tenth and FGR
in singleton was defined as weight centile below the third. Although the recent Delphi consensus
statement did not propose a definition for sFGR at birth, we applied the antenatal criteria of one twin
below the tenth weight centile and a weight discordance of more than 25% or the solitary criteria
of one twin with birthweight below the third centile [13]. The weight centiles were assessed using
the singleton standard reported by Poon et al. and twin chorionicity-specific standards reported by
Ananth et al. [7,23].
HDP included gestational hypertension and pre-eclampsia, as defined by the International
Society of Hypertension in Pregnancy (ISSHP) guideline [24]. Women with new-onset hypertension
(≥140 mm/Hg systolic or ≥90 mm/Hg diastolic on two separate occasions 12 h apart) were classified
as gestational hypertension or pre-eclampsia according to the presence of systemic involvement
(significant proteinuria or maternal organ dysfunction). Significant proteinuria was defined as a
protein/creatinine ratio (PCR) ≥30 mg/mmol. Other criteria of systemic involvement included liver
dysfunction (aspartate aminotransferase and alanine aminotransferase concentrations more than
twice the upper reference range), reduced platelet count (<100,000/µL), hemolysis (increased lactate
dehydrogenase concentration more than twice the upper reference range), renal failure (creatinine
>90 umol/L), or neurological symptoms (persistent severe headache, seizures).
PTB included both spontaneous onset and iatrogenic (medically indicated) deliveries prior to
34 weeks’ gestation. The cut-off was chosen to be 34 weeks instead of traditional 37 weeks because
most twin pregnancies are delivered between 37 to 38 weeks in our study center.
2.3. Statistical Analysis
Continuous variables were presented as median with interquartile ranges (IQR), and categorical
variables were presented as number and percentage of the total. Logistic regression analyses were used
to assess the association of HDP and GA at delivery with sFGR or SGA neonate. The receiver-operating
characteristics curves were used and the areas under the curve (AUC) were compared using De Long’s
test. p values below 0.05 were considered statistically significant. The statistical analysis was performed
using RStudio (Version 1.0.136, Rstudio, Inc., Boston, MA, USA) statistical software.
3. Results
3.1. Study Population
The analysis included 1473 twin and 62,432 singleton pregnancies. There were 1177 (80.0%)
dichorionic and 296 (20.0%) monochorionic twin pregnancies in the cohort. The incidence of HDP was
10.3% in twin and 5.0% in singleton pregnancies. Table 1 outlines baseline characteristics of the study
population for singletons and twins. Twin pregnancies delivered at a significantly earlier gestational
age compared to singletons (median: 36.9 vs. 40.0 weeks, p < 0.001). Preeclampsia (7.5% vs. 2.5%,
p < 0.001) and SGA at birth (50.0% vs. 13.6%, p < 0.001) were significantly more common in twin
than singleton pregnancies. The incidence of SGA newborn (24.8% vs. 50.0%, p < 0.001, McNemar’s
chi-squared test) and sFGR at birth (22.0% vs. 11.3%, p < 0.001, McNemar’s chi-squared test) were
significantly higher using the singleton compared to twin standards.
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Table 1. Characteristics of study cohort.
Variables Singleton Pregnancies(n = 62,432)
Twin Pregnancies
(n = 1473) p *
Maternal age in years, median (IQR) 31.0 (27.0–35.0) 33.0 (30.0–36.0) <0.001
Gestational age at birth in weeks, median (IQR) 40.0 (39.0–41.0) 36.9 (34.9–37.4) <0.001
Smoker, n (%) 3673 (5.8) 75 (5.2) 0.350
Missing 0 (0.0) 47 (3.2)
Self-reported ethnicity, n (%)
Caucasian 32,264 (51.7) 826 (56.1) <0.001
Afro-Caribbean 8996 (14.4) 216 (14.7) 0.812
Asian 8826 (14.1) 163 (11.1) <0.001
Mixed 1535 (2.4) 15 (1.0) <0.001
Other, prefer not to say 7587 (12.2) 150 (10.2) 0.0244
Missing 3224 (5.2) 103 (6.9)
Chorionicity, n (%) NA
DC NA 1177 (80.0)
MC NA 296 (20.0)
Hypertensive disorders of pregnancy, n (%)
Gestational hypertension 1511 (2.4) 42 (2.9) 0.328
Preeclampsia 1590 (2.5) 110 (7.5) <0.001
Birthweight in grams 3360 (3025–3700) 2430 (2058–2688) † <0.001
Birthweight centile 42.8 (19.5–70.1) 40.1 (23.5–58.5) † <0.001
Birthweight discordance %, median (IQR) NA 9.4 (4.2–16.6) NA
IQR: interquartile ranges, DC: dichorionic, MC: monochorionic, NA: not applicable. * Wilcoxon rank sum test or
chi-square where appropriate. † Average birthweight for twins.
3.2. SGA and FGR in Singleton Pregnancies
The incidence of SGA and FGR in singleton pregnancies was 13.6% (n = 8470) and 3.9% (n = 2763),
respectively. The risk of PTB <34 weeks without HDP (OR 2.82, p < 0.001), delivery ≥34 weeks with
HDP (OR 2.38, p < 0.001), and PTB <34 weeks with HDP (OR 13.65, p < 0.001) were significantly higher
in the pregnancies complicated by FGR compared to those without. The risk of PTB <34 weeks without
HDP (OR 1.43, p < 0.001), delivery ≥34 weeks with HDP (OR 1.77, p < 0.001), and PTB <34 weeks with
HDP (OR 10.26, p < 0.001) were significantly higher in the pregnancies complicated by SGA compared
to those without (Table 2).
3.3. SGA and FGR in Twin Pregnancies
3.3.1. FGF1. Selective FGR
When sFGR was assessed using the twin standard, the risk of PTB <34 weeks without HDP
(OR 3.55, p < 0.001), delivery ≥34 weeks with HDP (OR 3.17, p = 0.004), and PTB <34 weeks with HDP
(OR 5.69, p < 0.001) were significantly higher in the pregnancies complicated by sFGR compared to
those without. When sFGR was assessed using the singleton standard, the risk of PTB <34 weeks
without HDP (OR 1.03, p = 0.872) and delivery ≥34 weeks with HDP (OR 1.36, p = 0.160) were similar
in the pregnancies complicated by sFGR compared to those without, while the risk of PTB <34 weeks
with HDP was significantly higher in the pregnancies complicated by sFGR compared to those without
(OR 2.41, p = 0.025) (Table 2).
The stronger and more consistent association using the twin reference charts persisted in the
subgroup analyses according to chorionicity (Table 3). The AUC values of the models were also
consistently higher when the sFGR outcome was assessed using the twin standard with the largest
difference in the monochorionic twins subgroup (p < 0.050 for all) (Table 4, Figure S1).
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Table 2. The association of hypertensive disorders of pregnancy (HDP) and preterm birth (PTB) with small-for-gestational age (SGA) and fetal growth restriction
(FGR) at birth in singleton pregnancies. The diagnostic criteria for SGA and FGR were <10th and <3rd weight centile, respectively. Selective fetal growth restriction
(sFGR) for twins were diagnosed according to the Delphi consensus criteria.
Outcomes Singleton SGA(Singleton Chart *) p †
Twin SGA
(Singleton Chart) p Twin SGA (Twin Chart ‡) p
Delivery ≥34 weeks’ gestation without HDP Reference - Reference - Reference -
PTB <34 weeks’ gestation without HDP 1.43 (1.21–1.68) <0.001 0.56 (0.42–0.74) <0.001 3.10 (2.30–4.17) <0.001
Delivery ≥34 weeks’ gestation with HDP 1.77 (1.61–1.94) <0.001 1.41 (0.97–2.07) 0.074 2.12 (1.40–3.16) <0.001
PTB <34 weeks’ gestation with HDP 10.26 (7.88–13.41) <0.001 2.38 (1.08–5.79) 0.040 10.73 (4.83–26.22) <0.001
Outcomes Singleton FGR(Singleton Chart) p
Twin sFGR
(Singleton Chart) p Twin sFGR (Twin Chart) p
Delivery ≥34 weeks’ gestation without HDP Reference - Reference - Reference -
PTB <34 weeks’ gestation without HDP 2.82 (2.28–3.44) <0.001 1.03 (0.73–1.43) 0.872 3.55 (2.43–5.16) <0.001
Delivery ≥34 weeks’ gestation with HDP 2.38 (2.07–2.71) <0.001 1.36 (0.88–2.05) 0.160 2.17 (1.24–3.65) 0.004
PTB <34 weeks’ gestation with HDP 13.65 (10.36–17.86) <0.001 2.41 (1.08–5.18) 0.025 5.69 (2.39–12.65) <0.001
BW: birthweight, OR: odds ratio, CI: confidence interval, sFGR: selective fetal growth restriction, HDP: hypertensive disorders of pregnancy. * Birthweight was assessed using the standards
from Poon et al. [23]. † Generalized linear model with logit link function. ‡ Birthweight was assessed using the standards from Ananth et al. [7].
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Table 3. The association of hypertensive disorders of pregnancy (HDP) and preterm birth (PTB) with selective fetal growth restriction (sFGR) and small-for-gestational
age in monochorionic and dichorionic twin pregnancies. The diagnostic criteria for SGA and FGR were <10th and <3rd weight centile, respectively. Selective fetal
growth restriction was diagnosed according to the Delphi consensus criteria.
Outcomes
sFGR (Singleton Chart *) sFGR (Twin Chart †) SGA (Singleton Chart) SGA (Twin Chart)
OR (95% CI) p ‡ OR (95% CI) p OR (95% CI) p OR (95% CI) p
Dichorionic twin pregnancies
Delivery ≥34 weeks’ gestation without HDP Reference - Reference - Reference - Reference -
PTB <34 weeks’ gestation without HDP 0.71(0.45–1.09) 0.126
2.42
(1.50–3.80) <0.001
0.46
(0.32–0.64) <0.001
2.62
(1.84–3.72) <0.001
Delivery ≥34 weeks’ gestation with HDP 1.49(0.93–2.32) 0.084
2.01
(1.09–3.53) 0.018
1.37
(0.91–2.07) 0.135
1.91
(1.22–2.95) 0.003
PTB <34 weeks’ gestation with HDP 2.23(0.92–5.10) 0.061
4.62
(1.74–11.08) 0.001
2.85
(1.18–7.91) 0.028
11.98
(4.94–33.45) <0.001
Monochorionic twin pregnancies
Delivery ≥34 weeks’ gestation without HDP Reference - Reference - Reference - Reference -
PTB <34 weeks’ gestation without HDP 2.01(1.11–3.63) 0.020
9.19
(4.32–20.7) <0.001
0.87
(0.50–1.49) 0.608
5.53
(3.02–10.27) <0.001
Delivery ≥34 weeks’ gestation with HDP 0.71(0.16–2.26) 0.599
3.24
(0.68–11.7) 0.093
1.66
(0.64–4.63) 0.305
3.60
(1.25–9.78) 0.013
PTB <34 weeks’ gestation with HDP 3.78(0.44–32.31) 0.189
17.27
(1.93–155.7) 0.006
0.97
(0.11–8.21) 0.976
6.18
(0.72–53.22) 0.074
sFGR: selective fetal growth restriction, HDP: hypertensive disorders of pregnancy, BW: birthweight, OR: odds ratio, CI: confidence interval. * Generalized linear model with logit link
function. † Birthweight was assessed using the standards from Poon et al. [23]. ‡ Birthweight was assessed using the standards from Ananth et al. [7].
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Table 4. The area under the curve (AUC) values of the various study outcomes predicted by gestational
age at delivery and the occurrence of hypertensive disorders of pregnancy. The diagnostic criteria for
SGA and FGR were <10th and <3rd weight centile, respectively. Selective fetal growth restriction was
diagnosed according to the Delphi consensus criteria.
Outcome AUC (95% CI),Singleton Standard *
AUC (95% CI),
Twin Standard † p ‡
All twin pregnancies
sFGR at birth 0.52 (0.49–0.55) 0.64 (0.60–0.68) < 0.001
Any SGA at birth 0.56 (0.54–0.58) 0.62 (0.59–0.65) < 0.001
Dichorionic twin pregnancies
sFGR at birth 0.54 (0.51–0.58) 0.60 (0.55–0.65) 0.028
Any SGA at birth 0.57 (0.54–0.59) 0.61 (0.58–0.64) 0.026
Monochorionic twin pregnancies
sFGR at birth 0.58 (0.52–0.65) 0.75 (0.68–0.83) < 0.001
Any SGA at birth 0.53 (0.47–0.58) 0.69 (0.63–0.76) < 0.001
sFGR: selective fetal growth restriction, SGA: small-for-gestational-age, AUC: area under the curve, CI: confidence
interval. * Birthweight was assessed using the standards from Poon et al. [23]. † Birthweight was assessed using the
standards from Ananth et al. [7]. ‡ De Long’s test, one-tailed.
3.3.2. SGA of One or Both Twins
When SGA was assessed using the twin standard, the risk of PTB <34 weeks without HDP
(OR 3.10, p < 0.001), delivery ≥34 weeks with HDP (OR 2.12, p < 0.001) and <34 weeks with HDP (OR
10.73, p < 0.001) were significantly higher in the pregnancies complicated by SGA compared to those
without. When SGA was assessed using the singleton standard, the risk of PTB <34 weeks without
HDP (OR 0.56, p < 0.001) was significantly lower, while the risk of PTB <34 weeks with HDP (OR 2.38,
p = 0.040) was significantly higher in the pregnancies complicated by SGA compared to those without
(Table 2). The risk of delivery ≥34 weeks with HDP (OR 1.41, p = 0.074) was not significantly difference
in the pregnancies complicated by SGA compared to those without (Table 2).
The stronger and more consistent association using the twin reference charts persisted in the
subgroup analysis according to chorionicity (Table 3). The AUC value of the models were also
consistently higher (p < 0.050 for all) when any SGA outcome was assessed using the twin standard
(Table 4, Figure S1) with the largest difference in the monochorionic twins’ subgroup.
The strength of association in dichorionic twin pregnancies resembles that of the singletons more
closely and consistently when the FGR/SGA was assessed using the twin-specific charts (Figure 1).
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Figure 1. The association of hypertensive disorders of pregnancy (HDP) and preterm birth (PTB)
with fetal growth restriction (FGR) or small-for-gestational age (SGA) in dichorionic twin versus
singleton pregnancies. The association in twins resembles the association in singletons only when the
outcome is assessed with twin-specific birthweight charts. SGA: small for gestational age–birth weight
<10th centile, FGR: fetal growth restriction–birth weight <3rd centile, sFGR: selective fetal growth
restriction–Delphi consensus, HDP: hypertensive disorders of pregnancy. The dot points represent
the odds ratio and the lines represent the 95% confidence interval. Confidence intervals crossing the
reference (black line, odds ratio = 1) indicate a statistically insignificant association. The x-line is
truncated at 15.
4. Discussion
4.1. Summary of Main Results
Our study findings demonstrate that the association between FGR in twin pregnancies is
significantly and consistently associated with HDP and PTB when using the twin-specific charts, but
not with singleton charts. This association is valid in both dichorionic, as well as monochorionic
twin pregnancies. This study adds to the body of evidence suggesting that singleton standards
inflate the incidence of growth abnormalities in twins without identifying more pregnancies at risk of
adverse outcomes.
4.2. Strengths and Limitations
There are several strengths to our study. Firstly, this was a large cohort of twin pregnancies and
included both dichorionic and monochorionic pregnancies. Secondly, we excluded monochorionicity-
specific complications, such as TTTS, TAPS and TRAPS and major fetal structural abnormalities in view
of their know association with FGR and PTB. Thirdly, our analysis included a priori sensitivity analysis
according to chorionicity. Fourthly, we decided to use singleton and twin standards which were not in
clinical use in our center in order to minimize the risk of potential bias. Finally, we included livebirth
pregnancies only in order to avoid the risk of overestimating the incidence of SGA or FGR; stillbirth is
known to be associated with HDP and PTB. However, some limitations apply to the interpretation
of our results. First, as we excluded stillbirth cases, this may have reduced the number of FGR/SGA
cases. However, since we assessed the outcomes using the birthweight, the inclusion of stillbirth
cases was not possible and might have introduced a systematic bias. Second, we did not incorporate
some antenatal markers known to be associated with adverse outcomes such as estimated fetal weight
or fetal Doppler [25]. However, we tested the association of the same factors by only changing the
outcome variable. Therefore, whatever residual confounder effect left unaddressed should apply to all
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models in equal measure. Third, we only used one twin-specific birthweight standard among many
available charts and the utility of other twin-specific standards is yet to be investigated. The same
issue applies to singleton charts as well. Although there are more popular singleton charts available,
we opted to use a chart that was not in active use, derived from a similar population in London and
vetted for accuracy in our previous studies [8,26]. Lastly, we did not exclude spontaneous PTB without
adverse events, which is a potential confounder in our analysis.
4.3. Interpretation of Study Findings and Comparison with Published Literature
Few studies looked at the association of twin-specific growth standards with clinical adverse
outcomes [8,18]. The findings of the study by Kalafat et al. have suggested that twin-specific
growth standards could identify the same number of twin pregnancies with SGA and stillbirth as the
singleton charts, while labeling fewer pregnancies with liveborn fetuses as complicated with growth
abnormalities. More recently, Proctor et al. have demonstrated that the association of HDP with
live-born FGR babies is significantly stronger and more consistent when FGR is diagnosed using
twin-specific charts. Our study confirms their findings even though we used different singleton
and twin-specific birthweight charts. We also demonstrated that the association of HDP and PTB
more closely resembles the association in singletons if the outcome (FGR or SGA) is assessed with
a twin-specific chart. Moreover, we observed that the recently proposed sFGR diagnostic criteria
applied to birthweight had a stronger and more consistent relationship with adverse events such as
HDP and PTB. Couck et al. have studied the utility of the new Delphi consensus criteria for detecting
perinatal adverse outcomes at different gestational ages and compared it to estimated fetal weight
(EFW) discordance [10]. They reported similar predictive value but they used an EFW chart derived
from a singleton population. Future studies could test the performance of twin-specific EFW standards
in this context [27]. Furthermore, the utility and the choice of the various EFW and birthweight
standards remain controversial.
4.4. Clinical and Research Implications
An initiative to facilitate and improve the quality of research in multiple pregnancy is
ongoing [13,17]. The harmonization of the reported outcomes and their definitions is an important
goal for reproducible research and robust summarization of evidence. However, harmonizing of the
outcome definitions alone may not suffice as the reference standards also play a role in the assessment
of outcomes such as fetal weight. Our findings suggest that twin-specific standards better reflect the
association between HDP and adverse clinical outcomes such as FGR or SGA at birth. A perennial
criticism of the twin-specific growth charts is that they may obscure pathological growth trajectories
and under-detect at-risk fetuses. Our results show that birthweight anomalies, as assessed using
twin-specific charts, have a better and more consistent association with adverse outcomes compared
to assessment using singleton charts. Twin-specific charts were previously shown to reduce the rate
of SGA diagnosis without increasing the rate of undetected SGA stillbirth cases [8]. Accumulating
evidence suggests that twin-specific charts may be a viable option to reduce the over diagnosis of
growth abnormalities and the resulting risk of iatrogenic prematurity, as well as better identification of
the pregnancies at risk of complications such as HDP.
5. Conclusions
Fetal growth restriction in twin pregnancies has a stronger and more consistent association with
adverse events such as HDP and PTB when using twin-specific rather than singleton charts. This study
provides further evidence supporting the use of twin-specific charts when assessing fetal growth in
twin pregnancies.
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